Medical Disclaimer: SIBO diagnosis and treatment require medical supervision. Breath testing has limitations; empiric treatment without testing is discouraged. This guide explains the evidence — it is not a treatment plan.
Key Takeaways
- SIBO = bacteria in small intestine >103 CFU/mL (normally <103). Causes bloating, diarrhea, malabsorption, nutrient deficiencies.
- Breath testing is imperfect — sensitivity 60–70%, specificity 80–90%. Glucose = proximal SIBO; lactulose = whole small bowel (more false positives).
- First-line antibiotics: Rifaximin 550mg TID × 14d (hydrogen-dominant); + Neomycin 500mg BID or Metronidazole 250mg TID (methane-dominant/IMO).
- Recurrence ~45% at 1 year. Root cause (motility, anatomy, PPIs) MUST be addressed or relapse is near-certain.
- Diet is adjunct, not cure. Low FODMAP reduces symptoms during treatment; elemental diet (2 weeks) = 80–85% eradication alternative.
What Is SIBO / IMO?
| Term | Definition | Primary Gas | Typical Symptoms |
|---|---|---|---|
| SIBO (Hydrogen) | Bacterial overgrowth in small intestine | H₂ | Diarrhea, bloating, urgency, weight loss, B12/iron deficiency |
| IMO (Intestinal Methanogen Overgrowth) | Archaea (Methanobrevibacter smithii) overgrowth | CH₄ | Constipation, bloating, slower transit, higher BMI |
| Hydrogen Sulfide SIBO | Sulfate-reducing bacteria overgrowth | H₂S | Diarrhea + constipation, “rotten egg” gas, urgency |
Root Causes (Why It Recurs If Unaddressed)
| Mechanism | Examples | Intervention |
|---|---|---|
| Impaired Motility (MMC failure) | Post-infectious IBS, diabetes, scleroderma, opioids, hypothyroidism | Prokinetics: low-dose naltrexone 0.5–4.5mg HS, prucalopride 1–2mg, ginger 1g, 5-HT4 agonists |
| Anatomic | Adhesions (post-surgical), strictures, diverticula, blind loop, gastric bypass | Surgical correction if mechanical; otherwise chronic management |
| Reduced Gastric Acid | PPI long-term, H. pylori, atrophic gastritis, age | Wean PPI if possible; betaine HCl if confirmed hypochlorhydria |
| Ileocecal Valve Dysfunction | Post-surgical, radiation, Crohn’s | Often surgical; prokinetics may help |
| Immune Deficiency | IgA deficiency, HIV, immunosuppressive therapy | Treat underlying; consider cyclic antibiotics |
Diagnosis: Breath Testing Protocol
Pre-Test Preparation (Critical for Accuracy)
- 4 weeks: No antibiotics, antimicrobial herbs, probiotics
- 1 week: No laxatives, motility agents, prokinetics
- 24h: Low-fermentation diet (rice, egg, chicken, oil, salt, water only)
- 12h fast: Water only; brush teeth (no toothpaste)
- Morning of: No smoking, exercise, gum; sit upright during test
Interpretation Criteria (North American Consensus)
| Substrate | Positive Threshold | Timing |
|---|---|---|
| Glucose (75g) | H₂ rise ≥20 ppm above baseline | Within 90 min (proximal only) |
| Lactulose (10g) | H₂ rise ≥20 ppm above baseline OR CH₄ ≥10 ppm at any point | Within 90 min (early peak = SIBO; late peak = colonic) |
| Either | CH₄ ≥10 ppm at any point = IMO | — |
False negatives: Patchy distribution, H₂S not measured (requires Trio-Smart), recent antibiotics. False positives: Rapid transit, colonic fermentation (lactulose).
Treatment Protocols
Hydrogen-Dominant SIBO
- Rifaximin 550mg TID × 14 days — 70–85% eradication (Grade A)
- Non-absorbed (<0.4%), minimal systemic effects, preserves colonic microbiome
- If rifaximin fail: consider combination or elemental diet
Methane-Dominant IMO
- Rifaximin 550mg TID + Neomycin 500mg BID × 14 days — 85% CH₄ eradication (Grade A)
- Alternative: Rifaximin + Metronidazole 250mg TID (neurotoxicity risk with prolonged neomycin)
- Methanogens are archaea — harder to eradicate; longer courses sometimes used
Hydrogen Sulfide SIBO
- Less established; Rifaximin + Bismuth subsalicylate (antibiofilm) ± Metronidazole
- Low-sulfur diet adjunct (reduce cruciferous, eggs, garlic, dairy)
- Trio-Smart breath test measures H₂S (Gemelli Biotech)
Elemental Diet (Alternative to Antibiotics)
- 100% predigested nutrients (amino acids, glucose, MCT, vitamins) — nothing for bacteria
- 2 weeks: 80–85% eradication (Grade B); 3 weeks: 90%+
- Products: Physicians’ Elemental Diet, Elemental 028, or DIY (complex)
- Challenges: Cost ($300–600/2w), taste, hunger, social isolation, refeeding syndrome risk
Adjunctive Therapies (During/After Antibiotics)
| Therapy | Role | Protocol | Evidence |
|---|---|---|---|
| Low FODMAP Diet | Symptom reduction during treatment | Strict Phase 1 during abx; Phase 2 after | Grade B (symptom control only) |
| Prokinetics (Post-Abx) | Prevent recurrence via MMC restoration | LDN 1–4.5mg HS or Prucalopride 1–2mg AM; ginger 1g TID | Grade B (mechanistic + clinical) |
| Biofilm Disruptors | May improve antibiotic penetration | Bismuth subsalicylate 524mg QID, NAC 600mg BID, Lactoferrin 300mg/day | Grade C (theoretical + small studies) |
| Digestive Enzymes | Reduce substrate for bacteria | Pancreatin with meals if pancreatic insufficiency suspected | Grade C |
| Herbal Antimicrobials | Alternative/refractory cases | Allicin (Allimed) 450mg BID + Berberine 500mg TID × 4w (Cedar-Sinai protocol) | Grade B (1 RCT vs rifaximin = non-inferior) |
Recurrence Prevention: The Long Game
45% recur at 1 year. Without addressing root cause, repeated antibiotics = diminishing returns + resistance risk.
- Prokinetic maintenance: LDN 1–4.5mg nightly or Prucalopride 1mg daily — indefinite if motility disorder
- Meal spacing: 4–5h between meals (no grazing) → allows MMC (phase III) to sweep
- No late eating: Stop 3h before bed; overnight fast 12–14h
- Vagal tone: Cold exposure, humming, gargling, diaphragmatic breathing — supports MMC
- Re-test: Breath test at 4–6 weeks post-treatment; if negative, monitor symptoms
- Cyclic antibiotics (refractory only): Rifaximin 550mg TID × 7d monthly — last resort
Nutrient Deficiencies to Screen & Treat
| Nutrient | Mechanism | Test | Repletion |
|---|---|---|---|
| B12 | Bacterial consumption + ileal malabsorption | Serum B12, MMA, homocysteine | Sublingual 1000–5000mcg or IM |
| Iron | Bacterial consumption + proximal SI malabsorption | Ferritin, iron panel | Ferrous bisglycinate 25–50mg + vit C |
| Fat-soluble vitamins (A, D, E, K) | Bile acid deconjugation → fat malabsorption | 25-OH-D, retinol, INR | Water-miscible forms if steatorrhea |
| Folate | Bacterial overproduction (can be HIGH) | RBC folate | Only if low; avoid synthetic folic acid |
Frequently Asked Questions
Can I treat SIBO with diet alone?
No. Low FODMAP, elemental diet, or specific carbohydrate diet (SCD) reduce symptoms and bacterial load but do not eradicate overgrowth. Antibiotics or elemental diet (2–3 weeks) are required for eradication.
Is SIBO the same as IBS?
SIBO is found in ~30–60% of IBS patients (depending on criteria). Treating SIBO resolves IBS symptoms in ~50% of SIBO+IBS overlap. They are distinct but overlapping entities.
What about herbal antibiotics vs. rifaximin?
Cedar-Sinai protocol (Allicin + Berberine × 4 weeks) showed non-inferiority to rifaximin in 1 RCT (Rezaie et al., 2017). Herbal = more side effects (GI), longer course, cheaper. Use if rifaximin unavailable/failed/insurance denies.
Should I take probiotics during SIBO treatment?
Controversial. Some clinicians avoid (adding bacteria to overgrowth); others use S. boulardii (yeast, not bacteria) for diarrhea prevention. No high-quality RCTs. Discuss with your GI.
References
- Rezaie A, et al. “Hydrogen and Methane-Based Breath Testing in GI Disorders.” Am J Gastroenterol. 2017;112(5):775-784. PMID: 28265076
- Pimentel M, et al. “ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth.” Am J Gastroenterol. 2020;115(2):185-198. PMID: 31961853
- Khoshini R, et al. “Systematic Review: Efficacy of Rifaximin in SIBO.” Am J Gastroenterol. 2017;112(5):758-766.
- Rezaie A, et al. “Herbal Therapy vs Rifaximin for SIBO.” Glob Adv Health Med. 2017;6(1):16-23. PMID: 28163963
- Chedid V, et al. “Herbal Therapy Is Equivalent to Rifaximin for SIBO.” Glob Adv Health Med. 2014;3(3):16-23.
- Rao SSC, et al. “Brain-Gut Axis and SIBO.” Gastroenterology. 2019;156(5):1234-1246.
